![Pamela A. Silver](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pamela A. Silver
Corporate Officer/Principal bei
Harvard Westlake School
Profil
Pamela A. Silver is the founder of Karyopharm Therapeutics, Inc., founded in 2008.
Dr. Silver is the founder of Kula Bio, Inc., founded in 2018.
Dr. Silver is also the founder of Petri..
Dr. Silver is a Professor at Harvard Westlake School.
Dr. Silver is Founding Pillar at Pillar Co Management LLC.
Dr. Silver was a Professor at Dana-Farber Cancer Institute, Inc. Dr. Silver was an Assistant Professor at Princeton University.
Aktive Positionen von Pamela A. Silver
| Unternehmen | Position | Beginn |
|---|---|---|
Harvard Westlake School
 Harvard Westlake School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 27.12.2010 |
Pillar Co Management LLC
 Pillar Co Management LLC Investment ManagersFinance Pillar VC invests in companies located across the globe primarily in United States. The firm focuses on broad range of sectors and industries. It participates in pre-seed and seed stage transactions with an investment size of USD 0.5 - 7 million. It acts as a lead investor and takes a seat on the board of directors. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Pamela A. Silver
| Unternehmen | Position | Ende |
|---|---|---|
Kula Bio, Inc.
 Kula Bio, Inc. Chemicals: AgriculturalProcess Industries Produces biofertilizers | Gründer | - |
Petri
 Petri Investment ManagersFinance Functions as an alternative investment manager | Gründer | - |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Corporate Officer/Principal | - |
| KARYOPHARM THERAPEUTICS INC. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Harvard Westlake School
Harvard Westlake School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Pillar Co Management LLC
Pillar Co Management LLC Investment ManagersFinance Pillar VC invests in companies located across the globe primarily in United States. The firm focuses on broad range of sectors and industries. It participates in pre-seed and seed stage transactions with an investment size of USD 0.5 - 7 million. It acts as a lead investor and takes a seat on the board of directors. | Finance |
Kula Bio, Inc.
Kula Bio, Inc. Chemicals: AgriculturalProcess Industries Produces biofertilizers | Process Industries |
Petri
Petri Investment ManagersFinance Functions as an alternative investment manager | Finance |
